Pharmaceutical Speakers' Bureaus, Academic Freedom, and the Management of Promotional Speaking at Academic Medical Centers
Graduate studies at Western
Journal of Law, Medicine and Ethics 40 (2):311-325 (2012)
|Abstract||Pharmaceutical companies routinely engage physicians, particularly those with prestigious academic credentials, to deliver “educational” talks to groups of physicians in the community to help market the company's brand-name drugs.Although presented as educational, and even though they provide educational content, these events are intended to influence decisions about drug selection in ways that are not based on the suitability and effectiveness of the product, but on the prestige and persuasiveness of the speaker. A number of state legislatures and most academic medical centers have attempted to restrict physician participation in pharmaceutical marketing activities, though most restrictions are not absolute and have proven difficult to enforce. This article reviews the literature on why Speakers' Bureaus have become a lightning rod for academic/industry conflicts of interest and examines the arguments of those who defend physician participation. It considers whether the restrictions on Speakers' Bureaus are consistent with principles of academic freedom and concludes with the legal and institutional efforts to manage industry speaking|
|Keywords||No keywords specified (fix it)|
|Categories||categorize this paper)|
|Through your library||Configure|
Similar books and articles
Robert Streiffer (2006). Academic Freedom and Academic-Industry Relationships in Biotechnology. Kennedy Institute of Ethics Journal 16 (2):129-149.
Thomas S. Huddle (2008). Drug Reps and the Academic Medical Center: A Case for Management Rather Than Prohibition. Perspectives in Biology and Medicine 51 (2):251-260.
Robin Barrow (2009). Academic Freedom: Its Nature, Extent and Value. British Journal of Educational Studies 57 (2):178 - 190.
Richard T. De George (2003). Ethics, Academic Freedom and Academic Tenure. Journal of Academic Ethics 1 (1):11-25.
Shaili Jain (2007). Understanding Physician-Pharmaceutical Industry Interactions. Cambridge University Press.
Alison M. Jaggar (2007). Teaching in Colorado: Not a Rocky Mountain High; Academic Freedom in a Climate of Repression. Teaching Philosophy 30 (2):149-172.
Alison M. Jaggar (2007). Teaching in Colorado. Teaching Philosophy 30 (2):149-172.
Dennis Hayes (2009). Academic Freedom and the Diminished Subject. British Journal of Educational Studies 57 (2):127 - 145.
Elizabeth A. Franz & Harlene Hayne (2006). The Preservation of Academic Freedom: Tenure is Not Enough. Behavioral and Brain Sciences 29 (6):576-577.
Chance W. Lewis & BethRené Roepnack (2007). Academic Freedom and Academic Tenure: Can They Survive in the Market Place of Ideas? [REVIEW] Journal of Academic Ethics 5 (2-4):221-232.
David Healy (2003). In the Grip of the Python: Conflicts at the University-Industry Interface. Science and Engineering Ethics 9 (1):59-71.
Terence Karran (2009). Academic Freedom in Europe: Reviewing Unesco's "Recommendation". British Journal of Educational Studies 57 (2):191 - 215.
Dale Murray & Heather Certain (2007). Pharmaceutical “Gift-Giving,” Medical Education, and Conflict of Interest. Journal of Philosophical Research 32 (Supplement):335-343.
Added to index2012-07-13
Total downloads3 ( #213,863 of 739,542 )
Recent downloads (6 months)1 ( #61,680 of 739,542 )
How can I increase my downloads?